Patients & Caregivers
Advocacy
Partners

WE ARE BIONEWS SERVICES

BioNews Services is a leading online health, science and research publication company that exists for one purpose: to serve people living with a rare disease. We do this by connecting them with current, trusted, relevant news and information. Delivered daily.

LEARN MORE ABOUT US

ENGAGING OUR READERS

  • "I think you are providing a wonderful service for those of us who have PF and need to know more as our doctors just don't have the time to spend with us. Thanks for being there!"

  • AMPLIFYING THE PATIENT VOICE

    "BioNews patient columnists, like me, are a source of accurate, reliable information about the diseases we live with. Often the news, opinions and experiences that I share will spark on-line conversation. I love making that kind of one-to-one connection."
    — Ed Tobias, Senior Patient Specialist for Multiple Sclerosis News Today

  • AMPLIFYING THE PATIENT VOICE

    "BioNews is providing daily coverage of a wide range of muscular conditions, delivering both research-based content and insightful columns from patient specialists. As a columnist for SMA News Today, I have the opportunity to share my story and educate others about what life with SMA is like."
    — Kevin Schaefer, Senior Community Outreach Director - SMA and Patient Specialist for SMA News Today
    Kevin Schaefer
    Director of Forums

  • AMPLIFYING THE PATIENT VOICE

    "As a cystic fibrosis patient, I’ve felt like my disease is more of an identity than a diagnosis. BioNews is a news source that masterfully compiles the research, the patient stories, and the highs and lows of having CF. It portrays the entire picture of what it means to live with this disease."
    — Reid D’Amico, CF Patient Columnist

COMMUNITIES

More than simple websites, BioNews’ web and social media platforms form vibrant, dynamic patient and caregiver communities. Across our 50+ rare disease platforms, users are engaging with our content daily and interacting with one another on how to overcome the difficulties of disease management. Some of our Rare Disease Platforms: